Medical Urgency Drives 40.6% Lung Transplant Priority. 03/20/26

Welcome to Cardiology Today – Recorded March 20, 2026. This episode summarizes 5 key cardiology studies on topics like Waitlist outcomes and Chagas cardiomyopathy. Key takeaway: Medical Urgency Drives 40.6% Lung Transplant Priority.. Article Links: Article 1: Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized Trial. (Journal of the American College of Cardiology) Article 2: Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial. (Circulation) Article 3: Influence of U.S. Lung Composite Allocation Score Components on Transplant Candidate Prioritization. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 4: Multi-center Open-Label Tacrolimus Inhalation Powder (TIP) Trial Evaluating Safety, Tolerability, Efficacy and Pharmacokinetics in Adult Lung Transplant Recipients with Significant Renal Impairment. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 5: Pediatric lung transplantation in Japan across legislative and allocation reforms: a nationwide registry analysis of waitlist and post-transplant outcomes. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Full episode page: https://podcast.explainheart.com/podcast/medical-urgency-drives-40-6-lung-transplant-priority-03-20-26/ Featured Articles Article 1: Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized Trial. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41396086 Summary: The A. N. S. W. E. R. minus H. F. trial investigated the efficacy of sacubitril-valsartan compared to enalapril in patients with Chagas cardiomyopathy and heart failure with reduced ejection fraction. This study specifically evaluated effects on cardiac remodeling, functional outcomes, biomarkers, and safety. The trial addressed a critical knowledge gap regarding treatment for a common cause of heart failure with reduced ejection fraction in Latin America. Article 2: Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41853846 Summary: A phase two randomized clinical trial investigated memantine as a novel pharmacological therapy for premature atrial contractions. Preclinical studies previously found that pharmacological antagonism of N-methyl-D-aspartate receptors with memantine suppressed atrial arrhythmias. This current trial leveraged the identified functional cardiac glutamatergic system to assess a new approach for suppressing premature atrial contractions. Article 3: Influence of U.S. Lung Composite Allocation Score Components on Transplant Candidate Prioritization. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41856261 Summary: Lung Composite Allocation Score Components on Transplant Candidate Prioritization. An analysis of the U. S. Composite Allocation Score system for lung transplant prioritization found that medical urgency was responsible for 40.6 percent of the variation in total scores. This occurred despite medical urgency constituting only 25 of the 100 possible Composite Allocation Score points. The study quantified each component’s contribution to total Composite Allocation Score variability following the system’s implementation in March 2023. Article 4: Multi-center Open-Label Tacrolimus Inhalation Powder (TIP) Trial Evaluating Safety, Tolerability, Efficacy and Pharmacokinetics in Adult Lung Transplant Recipients with Significant Renal Impairment. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41856260 Summary: Oral tacrolimus, a critical immunosuppressant after lung transplantation, is associated with significant renal impairment. Tacrolimus Inhalation Powder represents a therapeutic strategy designed to deliver the drug locally, potentially preventing graft rejection with lower systemic drug levels. This approach was investigated in adult lung transplant recipients with existing renal impairment to address the problem of tacrolimus-induced nephrotoxicity. Article 5: Pediatric lung transplantation in Japan across legislative and allocation reforms: a nationwide registry analysis of waitlist and post-transplant outcomes. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41856259 Summary: A nationwide registry analysis of pediatric lung transplantation in Japan revealed the impact of legislative and allocation reforms on waitlist and post-transplant outcomes. This study analyzed data from 1998 to 2024, demonstrating how outcomes changed across three eras defined by the 2010 legislative revision and 2020 pediatric priority rules. The analysis provided critical insights into the real-world effects of policy adjustments on this life-saving procedure. Transcript Today’s date is March 20, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized Trial. The A. N. S. W. E. R. minus H. F. trial investigated the efficacy of sacubitril-valsartan compared to enalapril in patients with Chagas cardiomyopathy and heart failure with reduced ejection fraction. This study specifically evaluated effects on cardiac remodeling, functional outcomes, biomarkers, and safety. The trial addressed a critical knowledge gap regarding treatment for a common cause of heart failure with reduced ejection fraction in Latin America. Article number two. Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial. A phase two randomized clinical trial investigated memantine as a novel pharmacological therapy for premature atrial contractions. Preclinical studies previously found that pharmacological antagonism of N-methyl-D-aspartate receptors with memantine suppressed atrial arrhythmias. This current trial leveraged the identified functional cardiac glutamatergic system to assess a new approach for suppressing premature atrial contractions. Article number three. Influence of U.S. Lung Composite Allocation Score Components on Transplant Candidate Prioritization. An analysis of the U. S. Composite Allocation Score system for lung transplant prioritization found that medical urgency was responsible for 40.6 percent of the variation in total scores. This occurred despite medical urgency constituting only 25 of the 100 possible Composite Allocation Score points. The study quantified each component’s contribution to total Composite Allocation Score variability following the system’s implementation in March 2023. Article number four. Multi-center Open-Label Tacrolimus Inhalation Powder (TIP) Trial Evaluating Safety, Tolerability, Efficacy and Pharmacokinetics in Adult Lung Transplant Recipients with Significant Renal Impairment. Oral tacrolimus, a critical immunosuppressant after lung transplantation, is associated with significant renal impairment. Tacrolimus Inhalation Powder represents a therapeutic strategy designed to deliver the drug locally, potentially preventing graft rejection with lower systemic drug levels. This approach was investigated in adult lung transplant recipients with existing renal impairment to address the problem of tacrolimus-induced nephrotoxicity. Article number five. Pediatric lung transplantation in Japan across legislative and allocation reforms: a nationwide registry analysis of waitlist and post-transplant outcomes. A nationwide registry analysis of pediatric lung transplantation in Japan revealed the impact of legislative and allocation reforms on waitlist and post-transplant outcomes. This study analyzed data from 1998 to 2024, demonstrating how outcomes changed across three eras defined by the 2010 legislative revision and 2020 pediatric priority rules. The analysis provided critical insights into the real-world effects of policy adjustments on this life-saving procedure. Thank you for listening. Don’t forget to subscribe. Keywords Waitlist outcomes, Chagas cardiomyopathy, Medical urgency, Memantine, Heart failure with reduced ejection fraction, Atrial electrophysiology, Premature atrial contractions, Allocation rules, Sacubitril-valsartan, Renal impairment, Legislative reform, Transplant prioritization, Atrial arrhythmias, Enalapril, Scientific Registry of Transplant Recipients, Cardiac remodeling, Immunosuppression, Tacrolimus, Tacrolimus Inhalation Powder, Japan, Lung transplantation, N-methyl-D-aspartate receptors, Pediatric lung transplantation, Composite Allocation Score. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Medical Urgency Drives 40.6% Lung Transplant Priority. 03/20/26 first appeared on Cardiology Today.